Literature DB >> 23847659

Effect of 1α-25-dihydroxyvitamin D3 on intimal hyperplasia developing in vascular anastomoses: a rabbit model.

Ismail Yurekli1, Orhan Gokalp, Muge Kiray, Mehmet Bademci, Ufuk Yetkin, Kazim Ergunes, Osman Yilmaz, Serdar Bayrak, Ali Gurbuz.   

Abstract

INTRODUCTION: A common problem encountered in routine daily practice of cardiovascular surgery is migration of smooth muscle cells leading to intimal hyperplasia developing at vascular anastomosis sites which then causes luminal narrowing. The aim of this study was to investigate the antiproliferative effect of 1,25 (OH)2D3 on intimal hyperplasia.
MATERIAL AND METHODS: Twenty-one male white New Zealand rabbits weighing 2-3 kg were selected. There were 3 groups of animals each consisting of 7 rabbits. Group 1 was the control group. Group 2 was the sham group and group 3 consisted of rabbits receiving 1,25 (OH)2D3. The right carotid arteries of the subjects in groups 2 and 3 were transected and re-anastomosed. A daily dose of 25 ng 1,25 (OH)2D3 per 100 g body weight was administered for 14 days to rabbits in group 3. Rabbits in group 2 were not subject to any pharmaceutical agent. All the subjects were sacrificed at the end of the 28(th) postoperative day. Their right carotid arteries were resected and then investigated histopathologically.
RESULTS: Intimal thickness and intimal area were measured as significantly lower in group 1 when compared with the other groups (p = 0.004). In group 3, the ratios of thickness of tunica intima/thickness of tunica media and area of tunica intima/area of tunica media were significantly lower than those of group 2 (p = 0.015, p = 0.003).
CONCLUSIONS: 1,25 (OH)2D3, the active metabolite of vitamin D, reduces the intimal hyperplasia developing after vascular anastomoses.

Entities:  

Keywords:  carotid artery; intimal hyperplasia; vitamin D

Year:  2012        PMID: 23847659      PMCID: PMC3701962          DOI: 10.5114/aoms.2012.30786

Source DB:  PubMed          Journal:  Arch Med Sci        ISSN: 1734-1922            Impact factor:   3.318


Introduction

Reconstructive surgery is a commonly used method as a treatment modality in obstructive arterial disease. Recently, the success of these interventions has been worse then expected due to spontaneous thrombus formation or development of stenosis. Contrary to acute occlusion immediately after vascular reconstructive interventions, where acute thrombus formation takes place, neointimal hyperplasia – developing after migration of smooth muscle cells and accumulation of collagen – plays an important role in pathogenesis of constriction or restenosis of the late period [1, 2]. Vitamin D is a significant regulator of calcium metabolism. It has an antiproliferative effect on some cell systems as well as on smooth muscle cells [3, 4]. Accordingly, in this study, we investigated the effect of 1,25 (OH)2D3 – the active form of vitamin D – on intimal hyperplasia.

Material and methods

This study was conducted according to the “Guide to the Care and Use of Experimental Animals (Canadian Council on Animal Care)” and we obtained approval from the Local Experimental Animal Ethics Committee of Dokuz Eylul University. During the course of the study, all rabbits were routinely fed with rabbit chow and tap water ad libitum. The rabbits were maintained on a 12: 12-h light: dark cycle in an environmentally monitored room with a ventilation system at a temperature of 20 ±2°C. Twenty-one male white New Zealand rabbits weighing 2-3 kg were selected. There were 3 groups of animals each consisting of 7 rabbits. Group 1 was the control group. Group 2 was the sham group and group 3 consisted of rabbits receiving 1,25 (OH)2D3. Animals in group 1 were not subject to any intervention and were sacrificed at the end of the 28th day using 150 mg of thiopental sodium per kg body weight (Pental, Ibrahim Ethem Ulagay, Istanbul, Turkey). Their right carotid arteries were resected. Preoperatively, auricular marginal veins of the rabbits were cannulated in group 2 and 3. Intramuscular injection of the mixture of 50 mg/kg body weight ketamine hydrochloride (Ketalar, Eczacıbaşı, Istanbul, Turkey) and 5 mg/kg body weight xylazine hydrochloride (Rompun, Bayer, Istanbul, Turkey) was performed. Intravenous cefazolin sodium (Sefazol, Mustafa Nevzat, Istanbul, Turkey) was administered at a dose of 50 mg/kg body weight for antibiotic prophylaxis. Providing aseptic conditions, a vertical right jugular incision was performed and a 3-cm segment of carotid artery was explored. Then, heparin sulfate (Liquemine, Roche, Turkey) was administered intravenously at a dose of 100 IU/kg body weight and the carotid artery was clamped proximally and distally with bulldog clamps. The same artery was then transected and re-anastomosed using 8/0 polypropylene suture. Subcutaneous and cutaneous tissues were closed. No additional drug was administered to the animals in group 2 and they were then sacrificed at the end of the 28th postoperative day using 150 mg of thiopental sodium per kg body weight. Their right carotid arteries were then resected. During the postoperative period, animals of group 3 received subcutaneous injections of 1,25 (OH)2D3 (Calcijex, Abbott, Turkey) at a daily dose of 25 ng/100 g body weight for 14 days. These animals were also sacrificed at the end of the 28th postoperative day as described above.

Histopathological examination

For light microscopic examination, segments of the carotid anastomotic site obtained from the sacrificed rabbits were immediately placed in 10% formalin in phosphate buffer overnight, processed by routine histological methods and embedded in paraffin blocks. Paraffin blocks were placed in a Leica RM2125 rotary microtome (Germany) and sections of 5 µm thickness were obtained. The sections were stained with both hematoxylin and eosin and Masson's trichrome stain in a standard manner. The images were analyzed by using a computer-assisted image analyzer system consisting of a microscope (Olympus BX-51, Tokyo, Japan) equipped with a high-resolution video camera (Olympus DP71, Japan). Anastomotic intimal hyperplasia was calculated at the site of maximum thickness by quantitative morphometric analysis with digital image analysis software (UTSCSA; Image tool version 3,0). The thickness of media, which was near to the anastomotic site and maintained normal structure, was also calculated. The areas of tunica intima and tunica media, diameters of vessels and their luminal areas were also calculated. All histomorphometric procedures were performed blindly.

Statistical analysis

Results are presented as medians (minimum – maximum values). All data were analyzed by Mann-Whitney test. Values of p below 0.05 was considered statistically significant.

Results

In groups 2 and 3, where vascular injury was formed by anastomosis, median intimal thickness was significantly higher than that of group 1, where the native arteries were kept without surgical intervention (p = 0.04) (Table I). The median intimal thickness was measured as < 0.01 mm in group 1, whereas this was measured as 0.105 (0.089-0.169) mm and 0.083 (0.080-0.120) mm, in group 2 and 3, respectively. The median intimal area was measured as 0.0307 (0.0187-0.0545) mm2 in group 1, whereas this was measured as 0.1364 (0.0595-0.2001) mm2 and 0.1497 (0.0470-0.2793) mm2, in group 2 and 3, respectively. This difference was also statistically significant (p = 0.004, p = 0.009). During histological examination of the sections, this increase in intimal thickness and area was observed to originate from increased collagen accumulation and proliferation of smooth muscle cells due to vascular injury (Figures 1A-C).
Table I

Histopathological measurements related to tunica intima and media

VariableGroup 1 (Control) (n = 7) Group 2 (Sham) (n = 7)Group 3 (Vitamin D) (n = 7)Value of p
Group 1-group 2Group 1-group 3Group 2-group 3
Intima thickness [µm]7.56 (6.48-8.18)105.1 (89.70-169.36)83.285 (80.30-120.52)0.0040.0040.180
Media thickness [µm]176.36 (161.06-179.94)144.23 (105.14-190.74)176.535 (123.77-237.38)0.1770.9310.180
Intima/media ratio0.0435 (0.04-0.05)0.82 (0.64-0.89)0.53 (0.38-0.70)0.0040.0040.015
Intima area [mm2]0.0307 (0.0187-0.0545)0.1364 (0.0595-0.2001)0.1497 (0.0470-0.2793)0.0040.0090.818
Media area [mm2]0.5327 (0.4447-0.5494)0.4253 (0.2786-0.5994)0.6069 (0.3032-1.4859)0.5370.1770.132
Intima area/media area0.06 (0.42-0.99)0.34 (0.09-0.52)0.20 (0.13-0.25)0.040.040.003
Figure 1

Histological sections of the carotid artery (Masson trichrome stain). A – Group 1, B – group 2, C – group 3. Carotid artery sections obtained from control group showed thin and intact lamina and collagen-rich adventitia (A). Accumulation of intimal collagen in the remaining two groups (B, C)

Histological sections of the carotid artery (Masson trichrome stain). A – Group 1, B – group 2, C – group 3. Carotid artery sections obtained from control group showed thin and intact lamina and collagen-rich adventitia (A). Accumulation of intimal collagen in the remaining two groups (B, C) Histopathological measurements related to tunica intima and media Although the median intimal thickness of the subjects in group 3 (anastomosis + 1,25 (OH)2D3) was measured as lower than that of subjects in group 2 (anastomosis only), this difference was statistically insignificant (p = 0.180) (Table I). In addition, median thickness of tunica media of the subjects in group 3 was higher than that of subjects in group 2, but with no statistical significance (p = 0.180) (Table I). Nevertheless, in group 3, the ratio of thickness of tunica intima/thickness of tunica media was significantly lower than that of group 2 (p = 0.015) (Table I). This ratio was calculated as 0.53 (0.38-0.70) in group 3, whereas it was calculated as 0.82 (0.64-0.89) in group 2. Although the median intimal area in group 3 was calculated as higher than that in group 2, this difference was statistically insignificant (p = 0.818) (Table I). Comparing these two groups in terms of median area of tunica media, it was calculated as 0.6069 (0.3032-1.4859) mm2 and 0.4253 (0.2786-0.5994) mm2 in group 3 and group 2, respectively. This difference was statistically insignificant. But, the primarily considered parameter is the ratio of area of tunica intima/area of tunica media when someone talks about intimal hyperplasia. This ratio was calculated as 0.20 (0.13-0.25) and 0.34 (0.09-0.52) in groups 3 and 2, respectively. This difference between ratios was statistically significant (p = 0.003) (Table I). In histological sections it was observed that 1,25 (OH)2D3 inhibited smooth muscle cell proliferation and collagen accumulation significantly, thus reducing the ratio of intima thickness/media thickness (Figure 2).
Figure 2

Histological sections of the carotid artery (hematoxylin and eosin stain). A – Group 1, B – group 2, C – group 3. The ratio of intimal thickness/media thickness was lower in group 3 than that of group 2. Arrowheads point at internal elastic laminae

Histological sections of the carotid artery (hematoxylin and eosin stain). A – Group 1, B – group 2, C – group 3. The ratio of intimal thickness/media thickness was lower in group 3 than that of group 2. Arrowheads point at internal elastic laminae

Discussion

The two most common methods used to create vascular injury in experimental settings regarding intimal hyperplasia are balloon catheterization and anastomosis models [1, 5–7]. Balloon catheterization creates intimal injury mostly whereas the anastomosis model injures all layers of the vessel wall. During balloon catheterization, the catheter balloon is inflated manually and this causes heterogeneity in terms of pressure applied. Many studies have shown that application of higher pressures increases the restenosis rates [8]. Another advantage of the anastomosis model over balloon catheter is involvement of all layers of the vessel wall, thus – we think – forming more intimal injury. Therefore, we thought that balloon catheterization may cause problems in terms of standardization of the experimental model and preferred anastomosis model. Since estrogen diminishes the neointimal response, we preferred male rabbits [9]. In our study, we observed that intimal hyperplasia developed in both anastomosis groups when compared with the control group with no anastomosis. This demonstrated that the anastomosis model created a successful vascular injury. Almost all surgical interventions of the arterial system cause vascular injury, thus leading to proliferation of the smooth muscle cells and intimal hyperplasia. After endothelial injury, platelet adhesion and aggregation take place at the site of injury. Growth factors and cytokines secreted by platelets, macrophages and activated endothelial cells cause proliferation of medial smooth muscle cells. Proliferated smooth muscle cells then migrate into the intima. Intimal hyperplasia develops after smooth muscle cell proliferation, and synthesis and accumulation of extracellular matrix in the tunica intima. In brief, the first stage of intimal hyperplasia is proliferation of smooth muscle cells and the second stage is migration of these cells into the tunica intima [5, 10–13]. In the light of all this knowledge, inhibition of smooth muscle cell proliferation would also diminish intimal hyperplasia. It was previously postulated that vitamin D and its metabolites interfered with cell proliferation, thus regulating apoptosis and controlling malignant cell growth and proliferation. These effects are seen on several cell types possessing vitamin D receptors. G1/S phase of the cell cycle forms the center of the antiproliferative effect of 1,25 (OH)2D3. Proliferating cells undergo a cycle: G0/G1 phase (most differentiated and non-dividing cells are in G1 phase), S phase (DNA synthesis takes place), G2 phase and the subsequent division (mitosis) phase (M phase). There are many studies published indicating that at pharmacological doses, 1,25 (OH)2D3 plays an inhibitory role at G1/S phase and interferes with cell division completely [14-16]. Although most of the studies related to the antiproliferative effect of vitamin D are associated with oncological issues, there are several studies investigating vascular smooth muscle cells. In one of these studies, Carthy et al. examined the effect of 1,25 (OH)2D3 on vascular smooth muscle cells and epidermal growth factor (EGF) in cell culture media. They demonstrated that 1,25 (OH)2D3 inhibited growth of the vascular smooth muscle cells. Likewise, 1,25 (OH)2D3 suppressed the mitogenic effect of EGF on these cells [4]. Another study showed that 1,25 (OH)2D3 inhibited expression of the elastin gene in smooth muscle cells and proliferation of the smooth muscle cells. This effect was mediated by increasing the number of immature elastic fibers, thus relatively decreasing the number of mature elastic fibers [17]. Consistent with the literature data, in our study, it was demonstrated that intimal hyperplasia was diminished significantly in the group of animals administered 1,25 (OH)2D3 in comparison with the sham group due to inhibition of smooth muscle cell proliferation. To our knowledge, this study is the first study in the literature at tissue level demonstrating that 1,25 (OH)2D3 diminishes intimal hyperplasia developing after the anastomosis. Consequently, inhibition of proliferation of smooth muscle cells also inhibits intimal hyperplasia. Via its antiproliferative characteristics, 1,25 (OH)2D3 inhibits proliferation of smooth muscle cells and therefore diminishes development of intimal hyperplasia.
  15 in total

1.  Inhibitory effects of ticlopidine and clopidogrel on the intimal hyperplastic response after arterial injury.

Authors:  Tuğrul Göncü; Osman Tiryakioğlu; Ayhan Ozcan; Hasan Ari; Mustafa Sezen; Hakan Vural; Ahmet Bayer; Serhat Yalçinkaya; Senol Yavuz; Ahmet Ozyazicioğlu
Journal:  Anadolu Kardiyol Derg       Date:  2010-02

2.  Extracellular adenosine induces apoptosis of human arterial smooth muscle cells via A(2b)-purinoceptor.

Authors:  M L Peyot; A P Gadeau; F Dandré; I Belloc; F Dupuch; C Desgranges
Journal:  Circ Res       Date:  2000 Jan 7-21       Impact factor: 17.367

Review 3.  Antiproliferative effects of 1,25-dihydroxyvitamin D3 on breast cells: a mini review.

Authors:  P Bortman; M A A K Folgueira; M L H Katayama; I M L Snitcovsky; M M Brentani
Journal:  Braz J Med Biol Res       Date:  2002-01       Impact factor: 2.590

4.  A time sequence of vessel wall changes in an experimental model of angioplasty.

Authors:  R S More; G Rutty; M J Underwood; M J Brack; A H Gershlick
Journal:  J Pathol       Date:  1994-03       Impact factor: 7.996

5.  Tranilast inhibits vascular smooth muscle cell growth and intimal hyperplasia by induction of p21(waf1/cip1/sdi1) and p53.

Authors:  A Takahashi; T Taniguchi; Y Ishikawa; M Yokoyama
Journal:  Circ Res       Date:  1999-03-19       Impact factor: 17.367

Review 6.  Vitamin D and systemic cancer: is this relevant to malignant melanoma?

Authors:  J E Osborne; P E Hutchinson
Journal:  Br J Dermatol       Date:  2002-08       Impact factor: 9.302

7.  Early administration of YT-146, an adenosine A2 receptor agonist, inhibits neointimal thickening after rat femoral artery endothelium injury.

Authors:  Y Takiguchi; M Nagano; Y Ikeda; M Nakashima
Journal:  Eur J Pharmacol       Date:  1995-08-04       Impact factor: 4.432

8.  Inhibition of anastomotic intimal hyperplasia using a chimeric decoy strategy against NFkappaB and E2F in a rabbit model.

Authors:  Takashi Miyake; Motokuni Aoki; Ryuichi Morishita
Journal:  Cardiovasc Res       Date:  2008-05-31       Impact factor: 10.787

Review 9.  Antiproliferative role of vitamin D and its analogs--a brief overview.

Authors:  Pratik Banerjee; Malay Chatterjee
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

10.  Plasma asymmetric dimethylarginine predicts restenosis after coronary angioplasty.

Authors:  Arkadiusz Derkacz; Marcin Protasiewicz; Rafał Poręba; Adrian Doroszko; Małgorzata Poręba; Jolanta Antonowicz-Juchniewicz; Ryszard Andrzejak; Andrzej Szuba
Journal:  Arch Med Sci       Date:  2011-07-11       Impact factor: 3.318

View more
  1 in total

1.  Use of short prosthesis segments for brachiocephalic arteriovenous fistulas in elderly hemodialysis population.

Authors:  Jerzy Głowiński; Jolanta Małyszko; Irena Głowińska; Michał Myśliwiec
Journal:  Arch Med Sci       Date:  2014-02-23       Impact factor: 3.318

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.